Literature DB >> 12126046

11C-methionine uptake in cerebrovascular disease: a comparison with 18F-fDG PET and 99mTc-HMPAO SPECT.

Makoto Nakagawa1, Yasuo Kuwabara, Masayuki Sasaki, Hirofumi Koga, Tao Chen, Ouichirou Kaneko, Kazutaka Hayashi, Takato Morioka, Kouji Masuda.   

Abstract

OBJECTIVES: Carbon-11-L-methyl-methionine (11C-methionine) has been reported to be useful for evaluating brain tumors, but several other brain disorders have also shown signs of high methionine uptake. We retrospectively evaluated the significance of 11C-methionine uptake in cerebrovascular diseases, and also compared our results with those for 18F-FDG PET and 99mTc-HMPAO SPECT.
METHODS: Seven patients, including 3 patients with a cerebral hematoma and 4 patients with a cerebral infarction, were examined. All 7 patients underwent both 11C-methionine PET and 99mTc-HMPAO SPECT, and 6 of them underwent 18F-FDG PET.
RESULTS: A high 11C-methionine uptake was observed in all 3 patients with cerebral hematoma. Increased 99mTc-HMPAO uptake was observed in 2 out of 3 patients, and all 3 patients had decreased 18F-FDG uptake. Of 4 patients with a cerebral infarction, high 11C-methionine uptake was observed in 3. Increased 99mTc-HMPAO uptake was also observed in one patient, whereas 3 patients had decreased 18F-FDG uptake.
CONCLUSIONS: We should keep in mind that high 11C-methionine uptake is frequently observed in cerebrovascular diseases. CVD should therefore be included in the differential diagnosis when encounting patients with a high 11C-methionine uptake.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12126046     DOI: 10.1007/bf02996302

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  12 in total

Review 1.  11C-methionine PET/CT findings in benign brain disease.

Authors:  Reiko Nakajima; Ken Kimura; Koichiro Abe; Shuji Sakai
Journal:  Jpn J Radiol       Date:  2017-04-18       Impact factor: 2.374

2.  123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.

Authors:  Marleen Keyaerts; Tony Lahoutte; Bart Neyns; Vicky Caveliers; Chris Vanhove; Hendrik Everaert; Ken Kersemans; Philippe R Franken; John Mertens; Axel Bossuyt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-20       Impact factor: 9.236

3.  High uptake on 11C-methionine positron emission tomographic scan of basal ganglia germinoma with cerebral hemiatrophy.

Authors:  Akira Sudo; Tohru Shiga; Maki Okajima; Kyoko Takano; Satoshi Terae; Yutaka Sawamura; Akiko Ohnishi; Kazuo Nagashima; Shinji Saitoh
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

4.  Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.

Authors:  Alexander Becherer; Georgios Karanikas; Monica Szabó; Georg Zettinig; Susanne Asenbaum; Christine Marosi; Christine Henk; Patrick Wunderbaldinger; Thomas Czech; Wolfgang Wadsak; Kurt Kletter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-23       Impact factor: 9.236

5.  Diagnostics of cerebral gliomas with radiolabeled amino acids.

Authors:  Karl-Josef Langen; Klaus Tatsch; Anca-Ligia Grosu; Andreas H Jacobs; Matthias Weckesser; Osama Sabri
Journal:  Dtsch Arztebl Int       Date:  2008-01-25       Impact factor: 5.594

6.  11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.

Authors:  Tetsuhiro Hatakeyama; Nobuyuki Kawai; Yoshihiro Nishiyama; Yuka Yamamoto; Yasuhiro Sasakawa; Tomotsugu Ichikawa; Takashi Tamiya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-10       Impact factor: 9.236

7.  Early imaging findings in germ cell tumors arising from the basal ganglia.

Authors:  So Mi Lee; In-One Kim; Young Hun Choi; Jung-Eun Cheon; Woo Sun Kim; Hyun-Hae Cho; Sun Kyoung You
Journal:  Pediatr Radiol       Date:  2016-02-17

8.  Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.

Authors:  Keisuke Miyake; Aya Shinomiya; Masaki Okada; Tetsuhiro Hatakeyama; Nobuyuki Kawai; Takashi Tamiya
Journal:  J Biomed Biotechnol       Date:  2012-04-11

9.  Diagnostic Value of 11C-Methionine (MET) and 18F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis.

Authors:  Hajime Shishido; Nobuyuki Kawai; Keisuke Miyake; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Cancers (Basel)       Date:  2012-03-01       Impact factor: 6.639

10.  Imaging Spectrum and Pitfalls of (11)C-Methionine Positron Emission Tomography in a Series of Patients with Intracranial Lesions.

Authors:  Kimiteru Ito; Hiroshi Matsuda; Kazoo Kubota
Journal:  Korean J Radiol       Date:  2016-04-14       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.